Atypical antipsychotic drugs and hyperglycemia in adolescents

被引：32

作者：

Koller, E ^{[1
]}

Malozowski, S

Doraiswamy, PM

机构：

[1] US FDA, Ctr Drug Evaluat & Review, Rockville, MD 20857 USA

[2] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA

[3] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2001年 / 286卷 / 20期

关键词：

D O I：

10.1001/jama.286.20.2547

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：2547 / 2548

页数：2

共 8 条

[1]

*ABB LAB INC, 2000, VALPR PACK INS

[2]

[Anonymous], 1995, DIABETES AM

[3]

*IMS HEALTH, NAT DIS THER IND 199

[4]

*IMS HEALTH, NAT PRESCR AUD PLUS

[5]

KOLLER E, IN PRESS AM J MED

[6]

INCIDENCE OF DIABETES-MELLITUS BY CLINICAL TYPE [J].

MELTON, LJ ;

PALUMBO, PJ ;

CHU, CP .

DIABETES CARE, 1983, 6 (01) :75-86

[7]

Diabetic ketoacidosis associated with olanzapine in an adolescent patient [J].

Selva, KA ;

Scott, SM .

JOURNAL OF PEDIATRICS, 2001, 138 (06) :936-938

[8]

Drug-induced pancreatitis [J].

Wilmink, T ;

Frick, TW .

DRUG SAFETY, 1996, 14 (06) :406-423

← 1 →